BPMed Cosmetic CEO (2016-)

BoLCA+ Cosmetic Product

BPMed Holdings CEO (2014 - )

Botulinum Cosmetic Ingredient Development, Exclusive Rights

ATGC nonexecutive Director (2012 - )

Botulinum Pharmaceutical Ingredent R&D and Business Consulting

Meditox (2000 – 2011)

Executive of Meditoxin

(Botulinum Injection) Development

Yuhan Corporation R&D (1996 – 2000)

Development of Bio Pharmaceutical

Yuhan Chemical (1993 – 1995)

Development of Bio Pharmaceutical